Effects of melatonin on the expression of iNOS and COX-2 in rat models of colitis
- PMID: 12800246
- PMCID: PMC4611806
- DOI: 10.3748/wjg.v9.i6.1307
Effects of melatonin on the expression of iNOS and COX-2 in rat models of colitis
Abstract
Aim: To investigate the effects of melatonin (MT) on the expression of inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) in rat models of colitis.
Methods: Healthy adult Sprague-Dawlay (SD) rats of both sexes, weighing 280+/-30 g, were employed in the present study. The rat models of colitis were induced by either acetic acid or 2,4,6-trinitrobenzene sulfonic acid (TNBS) enemas. The experimental animals were randomly divided into melatonin treatment and model control group that were intracolicly treated daily with melatonin at doses of 2.5, 5.0, 10.0 mg/kg(-1) and equal amount of saline respectively from 24 h following induction of colitis in rats inflicted with acetic acid enema and the seventh day in rats with TNBS to the end of study. A normal control group of rats treated with neither acetic acid nor TNBS but saline enema was also included in the study. On the 28(th) day of the experiment, the rat colon mucosal damage index (CDMI) was calculated, and the colonic prostaglandin E(2) (PGE(2)), nitric oxide (NO), as well as the iNOS and COX-2 expression were also determined biochemically or immunohistochemically.
Results: CDMI increased to 2.87+/-0.64 and 3.12+/-1.12 respectively in rats treated with acetic acid and TNBS enema, which was in accordance with the significantly elevated colonic NO and PGE(2) contents, as well as the up-regulated colonic iNOS and COX-2 expression in both of the two rat models of colitis. With treatment by melatonin at the doses of 5.0 and 10.0 mg/kg(-1), CDMI in both models of rat colitis was significantly decreased (P<0.05-0.01), which accorded synchronously and unanimously with the reduced colonic NO and PGE(2) content, as well as the down-regulated expression of colonic iNOS and COX-2.
Conclusion: Melatonin has a protective effect on colonic injury induced by both acetic acid and TNBS enemas, which is probably via a mechanism of local inhibition of iNOS and COX-2 expression in colonic mucosa.
Figures


Similar articles
-
Ameliorative effects of sodium ferulate on experimental colitis and their mechanisms in rats.World J Gastroenterol. 2003 Nov;9(11):2533-8. doi: 10.3748/wjg.v9.i11.2533. World J Gastroenterol. 2003. PMID: 14606091 Free PMC article.
-
Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor.Cancer Res. 2002 Jan 1;62(1):165-70. Cancer Res. 2002. PMID: 11782374
-
Influence of simultaneous inhibition of cyclooxygenase-2 and inducible nitric oxide synthase in experimental colitis in rats.Inflammopharmacology. 2007 Oct;15(5):188-95. doi: 10.1007/s10787-007-1603-3. Inflammopharmacology. 2007. PMID: 17943250
-
Cyclooxygenase-2 downregulates inducible nitric oxide synthase in rat intestinal epithelial cells.Am J Physiol Gastrointest Liver Physiol. 2001 Sep;281(3):G688-96. doi: 10.1152/ajpgi.2001.281.3.G688. Am J Physiol Gastrointest Liver Physiol. 2001. PMID: 11518681
-
Inducible nitric oxide synthase: a little bit of good in all of us.Gut. 2000 Jul;47(1):6-9. doi: 10.1136/gut.47.1.6. Gut. 2000. PMID: 10861252 Free PMC article. Review.
Cited by
-
Melatonin ameliorates TNBS-induced colitis in rats through the melatonin receptors: involvement of TLR4/MyD88/NF-κB signalling pathway.Inflammopharmacology. 2019 Apr;27(2):361-371. doi: 10.1007/s10787-018-0523-8. Epub 2018 Aug 24. Inflammopharmacology. 2019. PMID: 30143913
-
Oxidative stress, hormones, and effects of natural antioxidants on intestinal inflammation in inflammatory bowel disease.Front Endocrinol (Lausanne). 2023 Aug 28;14:1217165. doi: 10.3389/fendo.2023.1217165. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37701897 Free PMC article. Review.
-
Distribution, function and physiological role of melatonin in the lower gut.World J Gastroenterol. 2011 Sep 14;17(34):3888-98. doi: 10.3748/wjg.v17.i34.3888. World J Gastroenterol. 2011. PMID: 22025877 Free PMC article. Review.
-
Melatonin and Cancer Hallmarks.Molecules. 2018 Feb 26;23(3):518. doi: 10.3390/molecules23030518. Molecules. 2018. PMID: 29495398 Free PMC article. Review.
-
Exploring the Therapeutic Potential of Rehmannia glutinosa: A Network Pharmacology and Molecular Docking Analysis Across Multiple Diseases.Curr Issues Mol Biol. 2025 May 3;47(5):329. doi: 10.3390/cimb47050329. Curr Issues Mol Biol. 2025. PMID: 40699728 Free PMC article.
References
-
- Sakamoto C. Roles of COX-1 and COX-2 in gastrointestinal pathophysiology. J Gastroenterol. 1998;33:618–624. - PubMed
-
- Kankuri E, Asmawi MZ, Korpela R, Vapaatalo H, Moilanen E. Induction of iNOS in a rat model of acute colitis. Inflammation. 1999;23:141–152. - PubMed
-
- Vural H, Sabuncu T, Arslan SO, Aksoy N. Melatonin inhibits lipid peroxidation and stimulates the antioxidant status of diabetic rats. J Pineal Res. 2001;31:193–198. - PubMed
-
- Cuzzocrea S, Reiter RJ. Pharmacological action of melatonin in shock, inflammation and ischemia/reperfusion injury. Eur J Pharmacol. 2001;426:1–10. - PubMed
-
- Bubenik GA. Gastrointestinal melatonin: localization, function, and clinical relevance. Dig Dis Sci. 2002;47:2336–2348. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials